Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on healthy human subjects with sensitive skin type. - NI

Dabur India Limited0 个研究点目标入组 24 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Subjects in age group 18 - 55 years (both the ages inclusive).
•Healthy male & female subjects.
•Subjects with Fitzpatrick skin type III to V.
•Subjects willing to give a voluntary written informed consent.
•Subjects willing to maintain the patch test in position for 24 hours.
•Subject having not participated in a similar investigation in the past two weeks.
•Subjects willing to come for regular follow up visits.
•Subjects ready to follow instructions during the study period.
•Subjects with sensitive skin type as per the score obtained from the skin type identification questionnaire in annexure-I and by dermatological evaluation for the confirmation of the same.

•Infection, allergy on the tested area.
•Skin allergy antecedents or atopic subjects.
•Athletes and subjects with history of excessive sweating.
•Cutaneous disease which may influence the study result.
•Subjects on oral corticosteroid.
•Subjects participating in any other cosmetic or therapeutic study.
•Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

发起方